Susquehanna International Group, LLP Abvc Biopharma, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$0.57 - $1.07 $2,221 - $4,169	3,897 Added 38.87%	13,923 $8,000
Q4 2022 Feb 14, 2023	SELL	$0.62 - $9.1 $11,325 - $166,229	-18,267 Reduced 64.56%	10,026 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.52 - $8.9 $14,712 - $251,807	28,293 New	28,293 $25,000
Q4 2021 Feb 14, 2022	SELL	$2.15 - $6.03 $32,415 - $90,914	-15,077 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.03 - $5.1 $30,606 - $76,892	15,077 New	15,077 $35,000

Ticker ABVC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,632,300
Market Cap $17M
Description
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.